Colonic inflammation in Parkinson's disease

Neurobiology of Disease

Volumn 50, Issue 1, 2013, Pages 42-48

  Devos, David ^a,b,c   Lebouvier, Thibaud ^a,b,c   Lardeux, Bernard ^a,b,c   Biraud, Mandy ^a,c   Rouaud, Tiphaine ^a,b,c   Pouclet, Hélène ^a,b,c   Coron, Emmanuel ^a,b,c   Bruley des Varannes, Stanislas ^a,b,c   Naveilhan, Philippe ^a,b,c   Nguyen, Jean Michel ^c   Neunlist, Michel ^a,b,c   Derkinderen, Pascal ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Colon; Enteric nervous system; Glial fibrillary acidic protein; Inflammation; Interferon gamma; Interleukin 1 beta; Interleukin 6; Parkinson's disease; Sox 10; Tumor necrosis factor alpha

Indexed keywords

ALPHA SYNUCLEIN; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEVODOPA; MESSENGER RNA; PROTEIN S100B; TRANSCRIPTION FACTOR SOX10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ASCENDING COLON; CLINICAL ARTICLE; COLITIS; COLON BIOPSY; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEALTH SURVEY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; UNIFIED PARKINSON DISEASE RATING SCALE;

ADULT; AGED; COLITIS; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; LEWY BODIES; MALE; MIDDLE AGED; PARKINSON DISEASE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84867823011     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.09.007     Document Type: Article

References (60)

1. Aube A.C., et al. Changes in enteric neurone phenotype and intestinal functions in a transgenic mouse model of enteric glia disruption. Gut 2006, 55:630-637.
2. Bassotti G., et al. Enteric glial cells: new players in gastrointestinal motility?. Lab. Invest. 2007, 87:628-632.
3. Beach T.G., et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2009, 119:689-702.
4. Benarroch E.E. Enteric nervous system: functional organization and neurologic implications. Neurology 2007, 69:1953-1957.
5. Bialecka M., et al. CARD15 variants in patients with sporadic Parkinson's disease. Neurosci. Res. 2007, 57:473-476.
6. Blum-Degen D., et al. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 1995, 202:17-20.
7. Bohnen N.I., et al. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain 2011, 134:2358-2365.
8. Braak H., et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
9. Braak H., et al. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci. Lett. 2006, 396:67-72.
10. Brochard V., et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Invest. 2009, 119:182-192.
11. Bush T.G., et al. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 1998, 93:189-201.
12. Christophi G.P., et al. Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease. Inflamm. Bowel Dis. 2012, 10.1002/ibd.22957.
13. Cirillo C., et al. Proinflammatory stimuli activates human-derived enteroglial cells and induces autocrine nitric oxide production. Neurogastroenterol. Motil. 2011, 23:e372-e382.
14. Cornet A., et al. Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease?. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13306-13311.
15. Damier P., et al. Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 1993, 52:1-6.
16. Elbaz A., Tranchant C. Epidemiologic studies of environmental exposures in Parkinson's disease. J. Neurol. Sci. 2007, 262:37-44.
17. Fahn S., et al. Unified Parkinson's disease rating scale. Recent development in Parkinson's disease. MacMillan Healthcare Information, Florham Park, NJ 1987, 153-163. S. Fahn (Ed.).
18. Farina C., et al. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007, 28:138-145.
19. Ferri G.L., et al. Evidence for the presence of S-100 protein in the glial component of the human enteric nervous system. Nature 1982, 297:409-410.
20. Forsyth C.B., et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One 2011, 6:e28032.
21. Gerhard A., et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol. Dis. 2006, 21:404-412.
22. Giulietti A., et al. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001, 25:386-401.
23. Hawkes C.H., et al. Parkinson's disease: a dual-hit hypothesis. Neuropathol. Appl. Neurobiol. 2007, 33:599-614.
24. Hirsch E.C., et al. Neuroinflammation in Parkinson's disease. Parkinsonism Relat. Disord. 2012, 18(Suppl. 1):S210-S212.
25. Hoff S., et al. Quantitative assessment of glial cells in the human and guinea pig enteric nervous system with an anti-Sox8/9/10 antibody. J. Comp. Neurol. 2008, 509:356-371.
26. Hughes A.J., et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
27. Jessen K.R., Mirsky R. Glial cells in the enteric nervous system contain glial fibrillary acidic protein. Nature 1980, 286:736-737.
28. Lakhan S.E., Kirchgessner A. Neuroinflammation in inflammatory bowel disease. J. Neuroinflammation 2010, 7:37.
29. Lebouvier T., et al. Pathological lesions in colonic biopsies during Parkinson's disease. Gut 2008, 57:1741-1743.
30. Lebouvier T., et al. Routine colonic biopsies as a new tool to study the enteric nervous system in living patients. Neurogastroenterol. Motil. 2010, 22:e11-e14.
31. Lebouvier T., et al. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One 2010, 5:e12728.
32. Liu Z., et al. The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat. Immunol. 2011, 12:1063-1070.
33. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
34. Matsuda R., et al. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naive ulcerative colitis during active and quiescent disease. Inflamm. Bowel Dis. 2009, 15:328-334.
35. McGeer P.L., McGeer E.G. Glial reactions in Parkinson's disease. Mov. Disord. 2008, 23:474-483.
36. McGeer P.L., et al. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988, 38:1285-1291.
37. Mogi M., et al. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci. Lett. 1994, 180:147-150.
38. Mogi M., et al. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett. 1994, 165:208-210.
39. Mogi M., et al. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci. Lett. 1996, 211:13-16.
40. Neunlist M., et al. Changes in chemical coding of myenteric neurones in ulcerative colitis. Gut 2003, 52:84-90.
41. Neunlist M., et al. Neuro-glial crosstalk in inflammatory bowel disease. J. Intern. Med. 2008, 263:577-583.
42. Parkkinen L., et al. Does levodopa accelerate the pathologic process in Parkinson disease brain?. Neurology 2011, 77:1420-1426.
43. Piche T., et al. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 2009, 58:196-201.
44. Pouclet H., et al. A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson's disease. Neurogastroenterol. Motil. 2012, 24:e202-e205.
45. Pouclet H., et al. A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease. Neurobiol. Dis. 2012, 45:305-309.
46. Przuntek H., et al. Diagnostic staging of Parkinson's disease: conceptual aspects. J. Neural Transm. 2004, 111:201-216.
47. Reale M., et al. Peripheral cytokines profile in Parkinson's disease. Brain Behav. Immun. 2009, 23:55-63.
48. Reimund J.M., et al. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 1996, 39:684-689.
49. Rome-Foundation Guidelines-Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. J. Gastrointestin. Liver Dis. 2006, 15:307-312.
50. Salat-Foix D., et al. Increased intestinal permeability and Parkinson disease patients: chicken or egg?. Can. J. Neurol. Sci. 2012, 39:185-188.
51. Savidge T.C., et al. Starring roles for astroglia in barrier pathologies of gut and brain. Lab. Invest. 2007, 87:731-736.
52. Schemann M., Neunlist M. The human enteric nervous system. Neurogastroenterol. Motil. 2004, 16(Suppl. 1):55-59.
53. Shannon K.M., et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov. Disord. 2012, 27:709-715.
54. Sigalet D.L., et al. Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293:G211-G221.
55. Sigalet D.L., et al. The effects of glucagon-like peptide 2 on enteric neurons in intestinal inflammation. Neurogastroenterol. Motil. 2010, 22:1318-e1350.
56. Sullivan K.E., et al. Measurement of cytokine secretion, intracellular protein expression, and mRNA in resting and stimulated peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol. 2000, 7:920-924.
57. Villaran R.F., et al. Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson's disease. J. Neurochem. 2010, 114:1687-1700.
58. von Boyen G.B., et al. Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia. Gut 2004, 53:222-228.
59. von Boyen G.B., et al. Distribution of enteric glia and GDNF during gut inflammation. BMC Gastroenterol. 2011, 11:3.
60. Wakabayashi K., et al. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol. 1988, 76:217-221.